Verastem

- NASDAQ:VSTM
Last Updated 2021-08-03
  • Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
  • Locations

    • Boston MA
  • Total Funding (USD)

    68.0 million
  • Industries

    Real Estate, Mobile Apps, Software, Cyber Security
  • Security

    Type: ORD
    CUSIP: 92337C104
    ISIN: US92337C1045
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.